Procyon Corp. (PCYN) intrinsic value & 10-year financials

Procyon Corp. (PCYN) has a Graham intrinsic value of $1.71 per share. At $0.27 on Oct 17, 2026, the stock trades 84% below that value. Over the last 10 fiscal years revenue grew 6.7% a year to $5.0M, with an average return on invested capital of -1.9%.

Graham intrinsic value
$1.71
Share price (Oct 17, 2026)
$0.27
Price vs Graham value
84% below
Market cap
$2.2M
Revenue (FY2024)
$5.0M
Revenue growth (10-yr CAGR)
6.7%
ROIC (10-yr avg)
-1.9%
Free cash flow (FY2024)
-$125.2K

PCYN 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2024 $5.0M -$341.1K -$0.04 -$125.2K -4.6% -10.1%
FY2023 $4.7M -$50.2K -$0.01 -$34.7K -2.1% -3.1%
FY2022 $4.8M -$209.8K -$0.03 -$312.1K -4.9% -8.9%
FY2021 $4.7M $767.6K $0.09 $214.3K 6.9% 12.6%
FY2020 $4.3M $111.7K $0.01 $175.7K 3.5% 5.1%
FY2019 $4.2M $27.2K $0.00 $22.1K 2.3% 2.4%
FY2018 $4.0M -$255.7K -$0.03 $39.8K 3.2% 2.9%
FY2017 $4.0M $12.4K $0.00 $180.7K 0.7% 0.7%
FY2016 $3.4M $109.6K -$0.01 -$54.6K -3.0% -4.7%
FY2015 $2.8M -$218.3K -$0.03 -$458.5K -12.3% -15.8%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

PROCYON CORP has demonstrated mature, steady growth, with revenue compounding at 6.7% annually over the past decade.

PROCYON CORP has historically struggled to out-earn its cost of capital, averaging just -1.9% ROIC.

PROCYON CORP has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, PROCYON CORP is modeled at 6.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $1.71 per share.

PCYN stock: frequently asked questions

What is the intrinsic value of Procyon Corp. (PCYN) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 6.7% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, PCYN's intrinsic value is about $1.71 per share.

Is PCYN stock undervalued?

At $0.27 (close on Oct 17, 2026), PCYN trades 84% below its Graham value of $1.71. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Procyon Corp. grown?

Revenue went from $2.8M in fiscal 2015 to $5.0M in fiscal 2024, a compound annual growth rate of 6.7%. Net income was -$341.1K in fiscal 2024.

Does Procyon Corp. generate free cash flow?

Procyon Corp. generated -$125.2K of free cash flow (operating cash flow minus capital expenditures) in fiscal 2024. Free cash flow was positive in 5 of the last 10 reported years.

What is PCYN's return on invested capital?

Average ROIC over the last 10 fiscal years was -1.9%, and average return on equity was -0.3%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this PCYN data come from?

From Procyon Corp.'s annual 10-K filings on SEC EDGAR, most recently filed Oct 25, 2024. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks